Syk-IN-3

CAS No. 1312534-69-2

Syk-IN-3( —— )

Catalog No. M33132 CAS No. 1312534-69-2

Syk-IN-3 is a Syk inhibitor with potential anti-inflammatory and anticancer activity and can be used to study immune dysregulation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 603 Get Quote
5MG 922 Get Quote
25MG 1398 Get Quote
50MG 1822 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Syk-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    Syk-IN-3 is a Syk inhibitor with potential anti-inflammatory and anticancer activity and can be used to study immune dysregulation.
  • Description
    Syk-IN-3, a potent spleen tyrosine kinase (Syk) inhibitor, extracted from patent WO2011075515A1, compound example 152, has an IC50 of 1 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    Syk
  • Recptor
    Syk
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1312534-69-2
  • Formula Weight
    452.57
  • Molecular Formula
    C24H28N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@]1(CC(C)(C)[C@@H](C(O)=O)CC1)C=2SC(=CN2)C3=CC(NC=4N=C(C)C=CN4)=CC(C)=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Muller S, et al. Donated chemical probes for open science.CITE?THIS ARTICLEAS:?eLife 2018;7:e34311.
molnova catalog
related products
  • Sovleplenib

    Sovleplenib (HMPL523) is an orally available, selective and potent inhibitor of the splenic tyrosine kinase SYK with an IC50 of 25 nM.Sovleplenib has antitumor activity and may be used in studies of immune thrombocytopenia (ITP).

  • Mitapivat

    Mitapivat, also known as PKM2 activator 1020 is a PKM2 activator (pyruvate kinase activator) for the treatment of pyruvate kinase deficiency.

  • Cevidoplenib dimesyl...

    Cevidoplenib dimesylate is an inhibitor of spleen tyrosine kinase (Syk), possessing anti-inflammatory and immunomodulating properties.